Overview

Immunity to Hepatitis B Vaccine

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Infection and cancer is a major cause of death and morbidity, and may be preventable through vaccination. It is not fully understood at the molecular level why some people respond better than others to vaccines until now the technology to assess this has not been available. This has impaired vaccine development. The overall goal of the Human Vaccines Project is to understand the 'rules' of how vaccines work. In this demonstration project the investigators will vaccinate healthy adults with hepatitis B vaccine to start to understand better how it works, ultimately helping with rational vaccine design in the future.
Phase:
Phase 4
Details
Lead Sponsor:
University of British Columbia
Collaborators:
Human Vaccines Project
Institut Pasteur
J. Craig Venter Institute
The Scripps Research Institute
University of California, San Diego
Vanderbilt University
Treatments:
Vaccines